科拓生物(300858) - 2024 Q3 - 季度财报

Revenue and Profit - Revenue for the third quarter was RMB 80,664,120.99, an increase of 4.74% year-over-year[2] - Net profit attributable to shareholders was RMB 27,675,939.24, a decrease of 12.62% year-over-year[2] - Net profit for the quarter was RMB 71.19 million, a slight decrease from RMB 72.01 million in the same period last year[17] - Sales revenue from goods and services was RMB 243.67 million, a decrease from RMB 285.88 million in the same period last year[19] - Total comprehensive income for the quarter was RMB 71.19 million, compared to RMB 72.01 million in the previous year[18] Assets and Liabilities - Total assets as of the end of the reporting period were RMB 1,850,679,243.44, an increase of 2.24% compared to the end of the previous year[2] - Total assets increased to 1,850,679,243.44 RMB, up from 1,810,100,800.90 RMB in the previous period[15] - Total liabilities rose to 86,011,661.28 RMB, compared to 77,099,673.09 RMB previously[16] - Owner's equity grew to 1,764,667,582.16 RMB, up from 1,733,001,127.81 RMB[16] - The monetary funds at the end of the period amounted to 130,122,749.32 yuan, a decrease from 191,596,438.14 yuan at the beginning of the period[14] - The trading financial assets at the end of the period amounted to 268,204,519.48 yuan, an increase from 152,262,249.57 yuan at the beginning of the period[14] - The accounts receivable at the end of the period amounted to 68,372,501.01 yuan, an increase from 65,395,480.10 yuan at the beginning of the period[14] - Inventory decreased to 33,866,230.33 RMB, down from 39,222,641.95 RMB[15] - Prepayments rose to 13,039,320.38 RMB, compared to 5,716,142.79 RMB previously[15] - Fixed assets increased to 344,316,124.53 RMB, up from 207,054,970.58 RMB[15] - Construction in progress decreased to 131,754,289.00 RMB, down from 156,652,040.89 RMB[15] - Accounts receivable increased to 1,124,389.79 RMB, up from 887,673.85 RMB[15] Cash Flow - Cash flow from operating activities was RMB 107,656,794.88, an increase of 32.44% year-over-year[2] - Cash received from other operating activities increased by 263.24% to RMB 52,258,423.24, mainly due to increased VAT refunds and government subsidies[8] - Cash received from investment recoveries increased by 32.92% to RMB 1,688,246,546.63 due to rolling cash management activities[8] - Total operating cash inflow was RMB 295.93 million, down from RMB 300.26 million in the same period last year[19] - Other income related to operating activities was RMB 52.26 million, a significant increase from RMB 14.39 million in the previous year[19] - Cash outflow from operating activities decreased to 188.27 million yuan from 218.98 million yuan, a reduction of 14.02%[20] - Net cash flow from operating activities increased to 107.66 million yuan from 81.28 million yuan, a growth of 32.45%[20] - Cash inflow from investing activities rose to 1.69 billion yuan from 1.27 billion yuan, an increase of 32.91%[20] - Net cash flow from investing activities improved to -125.53 million yuan from -553.78 million yuan, a significant reduction in outflow[20] - Cash outflow from financing activities decreased to 43.59 million yuan from 56.70 million yuan, a reduction of 23.12%[20] - Net cash flow from financing activities improved to -43.59 million yuan from -56.70 million yuan, a reduction in outflow[20] - Net increase in cash and cash equivalents improved to -61.46 million yuan from -529.20 million yuan, a significant reduction in outflow[20] - Ending cash and cash equivalents balance decreased to 127.07 million yuan from 346.10 million yuan, a reduction of 63.28%[20] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 9,379[9] - Sun Tiansong holds 19.94% of the shares, totaling 52,538,822 shares[9] - Ningbo Kerongda Venture Capital Partnership holds 10.23% of the shares, totaling 26,960,866 shares[9] - Zhang Liebing holds 6.39% of the shares, totaling 16,844,490 shares[9] - Qiao Xiangqian holds 4.51% of the shares, totaling 11,888,100 shares[9] - Ningbo Kehuida Venture Capital Partnership holds 4.42% of the shares, totaling 11,655,768 shares[9] - Liu Xiaojun holds 4.37% of the shares, totaling 11,510,495 shares[9] Expenses and Income - R&D expenses for the quarter were RMB 24.05 million, slightly down from RMB 24.69 million in the previous year[17] - Interest income increased to RMB 20.06 million from RMB 17.10 million in the previous year[17] - Financial expenses showed a negative value of RMB -19.80 million, compared to RMB -16.70 million in the previous year[17] - Income tax expense increased to RMB 8.49 million from RMB 6.77 million in the same period last year[17] - Government subsidies received during the reporting period amounted to RMB 4,136,358.05[3] - Investment income decreased by 64.29% to RMB 1,854,709.79 due to reduced returns from matured financial products[7] Operating Performance - Operating income reached 218,714,979.06 RMB, slightly higher than the previous 216,946,877.08 RMB[16] - Operating costs increased to 152,721,092.56 RMB, up from 148,503,966.53 RMB[16] - Prepaid expenses increased by 128.11% to RMB 13,039,320.38 due to increased prepayments for procurement and services[5] - Fixed assets increased by 66.29% to RMB 344,316,124.53 due to the transfer of some construction-in-progress to fixed assets[5] - Basic and diluted earnings per share remained stable at RMB 0.27[18]